首页 | 本学科首页   官方微博 | 高级检索  
     

重组蛋白sCAR-TMTP1增强腺病毒对骨肉瘤细胞基因转染效率的研究
引用本文:罗丹枫,龚静吉,程腾,魏睿,魏军成,祝文涛. 重组蛋白sCAR-TMTP1增强腺病毒对骨肉瘤细胞基因转染效率的研究[J]. 骨科, 2016, 7(6): 442-447. DOI: 10.3969/j.issn.1674-8573.2016.06.013
作者姓名:罗丹枫  龚静吉  程腾  魏睿  魏军成  祝文涛
作者单位:1. 华中科技大学同济医学院附属同济医院妇产科, 武汉,430030;2. 华中科技大学同济医学院附属同济医院骨科, 武汉,430030
基金项目:国家自然科学基金资助项目(81202061)
摘    要:目的 提高腺病毒(adenovirus,ADV)在缺乏柯萨奇腺病毒受体(coxsackie and adenovirus receptor,CAR)的骨肉瘤细胞中的转染效率.方法 通过昆虫(Bac-to-Bac)杆状病毒表达系统表达含有CAR胞外段(sCAR)及TMTP1肽的重组蛋白(sCAR-TMTP1),并对其纯化、鉴定.流式细胞仪分别检测骨肉瘤细胞及人胚肾细胞293(HEK293)的CAR表达水平,ADV对其的感染效率及FITC-TMTP1的结合能力.重组蛋白sCAR-TMTP1与ADV共同孵育形成复合物,流式细胞仪研究其在缺乏CAR的骨肉瘤细胞(MG-63)中的转染效率.结果 表达及纯化的sCAR-TMTP1蛋白在相对分子质量约31000处可见特异蛋白条带,感染的sf9细胞裂解上清可与兔抗小鼠sCAR单克隆抗体发生特异性反应.MG-63可与FITC-TMTP1特异结合,其CAR表达水平低,ADV转染效率低.经sCAR-TMTP1修饰后的ADV/GFP对MG-63细胞的感染效率显著高于未经修饰的含报告基因GFP的ADV(ADV/GFP).结论 重组蛋白sCAR-TM-TP1可显著提升ADV对缺乏CAR的骨肉瘤细胞的转染效率.

关 键 词:骨肉瘤  腺病毒  TMTP1肽  柯萨奇腺病毒受体  重组蛋白  基因治疗  肿瘤细胞
收稿时间:2016-08-25
修稿时间:2016-11-05

The recombinant fusion protein sCAR-TMTP1 enhances the gene transfer efficiency of ADV on human osteosarcoma cells
LUO Danfeng,GONG Jingji,CHENG Teng,WEI Rui,WEI Juncheng and ZHU Wentao. The recombinant fusion protein sCAR-TMTP1 enhances the gene transfer efficiency of ADV on human osteosarcoma cells[J]. Orthopaedics, 2016, 7(6): 442-447. DOI: 10.3969/j.issn.1674-8573.2016.06.013
Authors:LUO Danfeng  GONG Jingji  CHENG Teng  WEI Rui  WEI Juncheng  ZHU Wentao
Affiliation:Department of gynaecology and obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Department of Orthopaedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Abstract:Objective To enhance the transduction efficiency of adenovirus on coxsackievirus and adenovirus receptor (CAR) deficient human osteosarcoma cells. Methods The recombinant protein sCAR-TMTP1 was expressed and purified by Bac-to-Bac system, then identified by SDS-PAGE and Western blotting. The expression level of CAR and the infection efficiency of ADV/GFP in different cell lines (osteosarcoma cells& 293) were detected by flow cytometry (FCM), and the positive rate of FITC-TMTP1 binding to above cell lines was also measured by FCM. MG-63 cells were exposed to Ad/sCAR-ligand complexes mixtures, and the infection efficiency of ADV/GFP was measured by FCM. Results Either of expressed and purified sCAR-TMTP1 showed a specific protein band with a relative molecular mass of 31000, with which the supernatant of lysed sf9 cells infected showed specific reaction with rabbit anti-mouse sCAR monoclonal antibody. FITC-TMTP1 specifically bound to the MG-63 cells with a lower level of CAR and poor infection efficiency of ADV. ADV/GFP modified with sCAR-TMTP1 mediated an obvious enhancements of GFP expression in MG-63, compared with those cells exposed to ADV/GFP. Conclusion The recombinant fusion protein sCAR-TMTP1 has the ability to enhance the gene transfer efficiency of ADV on CAR deficient human osteosarcoma cells.
Keywords:Osteosarcoma  Adenovirus  TMTP1  Coxsackie and adenovirus receptor  Recombinant protein  Gene therapy  Tumer cell
本文献已被 万方数据 等数据库收录!
点击此处可从《骨科》浏览原始摘要信息
点击此处可从《骨科》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号